UA97249C2 - Комбинация ингибитора гистоновых дезацетилаз с объединенной активностью относительно гистоновых дезацетилаз класса i и класса ii в с ингибитором протеасом бортезомибом для угнетения роста опухолевых клеток - Google Patents
Комбинация ингибитора гистоновых дезацетилаз с объединенной активностью относительно гистоновых дезацетилаз класса i и класса ii в с ингибитором протеасом бортезомибом для угнетения роста опухолевых клетокInfo
- Publication number
- UA97249C2 UA97249C2 UAA200900388A UAA200900388A UA97249C2 UA 97249 C2 UA97249 C2 UA 97249C2 UA A200900388 A UAA200900388 A UA A200900388A UA A200900388 A UAA200900388 A UA A200900388A UA 97249 C2 UA97249 C2 UA 97249C2
- Authority
- UA
- Ukraine
- Prior art keywords
- class
- inhibiting
- growth
- inhibitors
- tumor cells
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Данное изобретение относится к комбинациям ингибитора протеасомы бортезомиба и ингибитора гистоновой дезацетилазы с объединенной активностью относительно гистоновых дезацетилаз класса I и класса IIB для ингибирования роста опухолевых клеток, который используется при лечении рака.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06120726 | 2006-09-15 | ||
PCT/EP2007/059518 WO2008031817A2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
UA97249C2 true UA97249C2 (ru) | 2012-01-25 |
Family
ID=41040414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200900388A UA97249C2 (ru) | 2006-09-15 | 2007-09-11 | Комбинация ингибитора гистоновых дезацетилаз с объединенной активностью относительно гистоновых дезацетилаз класса i и класса ii в с ингибитором протеасом бортезомибом для угнетения роста опухолевых клеток |
Country Status (12)
Country | Link |
---|---|
CN (1) | CN101516374B (ru) |
BR (1) | BRPI0716992A2 (ru) |
DK (1) | DK2066327T3 (ru) |
ES (1) | ES2399670T3 (ru) |
ME (1) | ME01514B (ru) |
NZ (1) | NZ575030A (ru) |
PT (1) | PT2066327E (ru) |
RS (1) | RS52638B (ru) |
SG (1) | SG177219A1 (ru) |
SI (1) | SI2066327T1 (ru) |
UA (1) | UA97249C2 (ru) |
ZA (1) | ZA200901818B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115028678A (zh) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | 基于vhl配体诱导bcr-abl蛋白降解的双功能分子及其制备方法和应用 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
CN107095871A (zh) * | 2016-02-22 | 2017-08-29 | 中国科学院上海巴斯德研究所 | Quisinostat,一种新型的高效抗疟药物 |
WO2018017858A1 (en) * | 2016-07-20 | 2018-01-25 | The Trustees Of Columbia University In The City Of New York | Histone acetyltransferase activators and compositions and uses thereof |
CN114409638B (zh) * | 2022-02-09 | 2023-02-14 | 深圳大学 | 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1781639B1 (en) * | 2004-07-28 | 2012-01-25 | Janssen Pharmaceutica NV | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
-
2007
- 2007-09-11 SI SI200731143T patent/SI2066327T1/sl unknown
- 2007-09-11 PT PT78033974T patent/PT2066327E/pt unknown
- 2007-09-11 UA UAA200900388A patent/UA97249C2/ru unknown
- 2007-09-11 RS RS20130038A patent/RS52638B/en unknown
- 2007-09-11 ME MEP-2013-15A patent/ME01514B/me unknown
- 2007-09-11 DK DK07803397.4T patent/DK2066327T3/da active
- 2007-09-11 SG SG2011092863A patent/SG177219A1/en unknown
- 2007-09-11 ES ES07803397T patent/ES2399670T3/es active Active
- 2007-09-11 CN CN200780034143.2A patent/CN101516374B/zh active Active
- 2007-09-11 NZ NZ575030A patent/NZ575030A/en unknown
- 2007-09-11 BR BRPI0716992-2A2A patent/BRPI0716992A2/pt not_active Application Discontinuation
-
2009
- 2009-03-13 ZA ZA200901818A patent/ZA200901818B/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115028678A (zh) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | 基于vhl配体诱导bcr-abl蛋白降解的双功能分子及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
PT2066327E (pt) | 2013-02-06 |
NZ575030A (en) | 2012-07-27 |
CN101516374B (zh) | 2013-04-24 |
ME01514B (me) | 2014-04-20 |
SG177219A1 (en) | 2012-01-30 |
ZA200901818B (en) | 2010-05-26 |
SI2066327T1 (sl) | 2013-04-30 |
DK2066327T3 (da) | 2013-02-11 |
CN101516374A (zh) | 2009-08-26 |
ES2399670T3 (es) | 2013-04-02 |
BRPI0716992A2 (pt) | 2013-09-17 |
RS52638B (en) | 2013-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008031820A3 (en) | Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors | |
WO2008031817A3 (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors | |
MX2009006542A (es) | Inhibidores de histona desacetilasa y sus profarmacos. | |
MX2007011148A (es) | Inhibidores de histona desacetilasa que sensibilizan celulas cancerosas respecto a los inhibidores de factor de crecimiento. | |
EA201101053A1 (ru) | Ингибиторы фосфоиноз итид-3-киназ с цинксвязывающей группой | |
MXPA06010900A (es) | Inhibidores de histona desacetilasa. | |
HK1087707A1 (en) | Inhibitors of histone deacetylase | |
TW200734315A (en) | Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase | |
WO2006060382A3 (en) | Use of hdac and/or dnmt inhibitors for treatment of ischemic injury | |
EP2099443A4 (en) | ASSOCIATION OF ERA + LIGANDS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER | |
WO2006055621A3 (en) | Histone deacetylase inhibitors and methods of use | |
MY183014A (en) | Compounds for enzyme inhibition | |
HK1125359A1 (en) | N-sulphonylpyrroles and their use as histone deacetylase inhibitors n- | |
MX349787B (es) | Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido. | |
MX336994B (es) | Compuestos de indolil o indolinil hidroxamato. | |
WO2008087643A3 (en) | Methods for enhancing the therapeutic efficacy of topoisomerase inhibitors | |
MX2009010485A (es) | Derivados de imidazolidinacarboxamida como inhibidores de lipasas y fosfolipasas. | |
UA97249C2 (ru) | Комбинация ингибитора гистоновых дезацетилаз с объединенной активностью относительно гистоновых дезацетилаз класса i и класса ii в с ингибитором протеасом бортезомибом для угнетения роста опухолевых клеток | |
TN2012000205A1 (en) | Method and compositions for treating solid tumors and other malignancies | |
WO2009076234A3 (en) | Synthesis methods of histone deacetylase inhibitors (hdacis) | |
WO2008082646A3 (en) | Histone deacetylase inhibitors, combination therapies and methods of use | |
MX2008008470A (es) | Nuevos derivados pirrolicos con actividad inhibidora de desacetilasa de histonas. | |
ZA200710497B (en) | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders | |
MX2011007373A (es) | Metodos para identificar pacientes que responderan bien a tratamiento para el cancer. | |
WO2008140708A8 (en) | Use of hdac inhibitors for treatment of cardiac rhythm disorders |